Search results
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 6 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 6 days agoThe biotechnology company, known for its mRNA vaccine technology, highlighted its strategic...
Public Health Professionals Must Engage The Public. Communications Training Is Key
Forbes· 21 hours agoFor a while, Covid-19 turned all journalists into health journalists. Equally, it pushed scientists...
Daily Brief: Tesla isn’t looking to hire
Quartz· 5 hours agoIt sure looks like Tesla has a hiring freeze. Elon Musk’s automaker quietly removed all of its U.S. job postings after weeks of “hardcore” layoffs. Tesla...
The Chinese scientist who sequenced covid is barred from his lab
The Economist· 7 days agoSince covid-19 emerged over four years ago in the central city of Wuhan, the Communist Party has...
The Summer That COVID Went Away?
US News & World Report· 6 days agoThe milestone came and went with little fanfare. After more than four years with COVID-19, the Centers for Disease Control and Prevention recently...
Could Avian Influenza Be The Next Covid-19?
Forbes· 3 days agoThe U.S. Centers for Disease Control and Prevention notified the public in early April that an individual in Texas had tested positive for highly...
Covid lessons remain unlearned as avian flu infects cattle, hospitals say
Politico via Yahoo News· 6 days agoMillions of doses of the vaccine that they believe could be useful for H5N1 are in government stockpiles, they said...are some ways in which an escalated response to H5N1 ...
Even as bird flu looms, the world is unlearning Covid’s lessons
Vox· 15 hours agoThe simmering fears over bird flu should leave no doubt: The health of humans and our fellow animals...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 7 days agoPfizer- $10.58 bn In the midst of the waning demand for Pfizer’sCovid-19 vaccine and antiviral Paxlovid (nirmatrelvir + ritonavir), ...
